Last reviewed · How we verify
NCT05532969
Correlation Between Psychological Stress and Progression of Diffuse Astrocytoma Towards Secondary Glioma
trial testing stressors in Astrocytoma in 60 participants. Not yet recruiting.
20 December 2025
Quick facts
| Lead sponsor | Henan Provincial People's Hospital |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 20 December 2022 |
| Primary completion | 20 December 2025 |
| Estimated completion | 20 December 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- stressors
Conditions studied
- Astrocytoma — all drugs for Astrocytoma →
Sponsor
Henan Provincial People's Hospital
Who can join
Adults 18 to 75, any sex, with Astrocytoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is a single-center, prospective, observational, non-randomized study of newly diagnosed diffuse astrocytoma patients conducted in a tertiary hospital. The investigators conduct an eight-year follow-up, including patients' psychological stress, immune biomarker changes, quality of life, and disease progression of patients towards secondary glioma after the first definite diagnosis. In the first year after diagnosis, patients are followed up four times at 1 month, 3 months, 6 months, and 12 months. After that, patients are followed up semiannually. The study had two cohorts, a high-stress cohort and a low-stress cohort, which are grouped after initial recruitment. Both groups undergo total resection of tumors and received 3 months of standardized treatment with radiotherapy and chemotherapy. Neither participants nor doctors but the researcher can choose which group participants are in. No one knows if one study group is better or worse than the other.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05532969
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of stressors
Trials testing the same drug.
- NCT05515133 — Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients · unknown
Other recruiting trials for Astrocytoma
Currently open trials in the same condition.
- NCT06989086 — FearLess in NeuroOncology · NA · recruiting
- NCT06614855 — A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant G · Phase 1 · active not recruiting
- NCT06797661 — Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions. · NA · recruiting
- NCT06344130 — Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma · Phase 1 · recruiting
- NCT05879367 — Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma · Phase 1 · recruiting
Other Henan Provincial People's Hospital trials
Trials by the same sponsor.
- NCT07250230 — Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Un · NA · recruiting
- NCT07268872 — Dynamic Effects of Different Anesthetic Agents on the Immune Function of Healthy Volunteers · NA · enrolling by invitation
- NCT07390929 — Clinical Trial Study on the Improved New Method of Acupotomy for AS · NA · recruiting
- NCT07033871 — Comprehensive Geriatric Assessment in Chronic Disease Management for Older Adults in China: A Registry Study （CGACDM - O · not yet recruiting
- NCT06929390 — Comparing BTVA and MWA in COPD With Early Lung Cancer: Efficacy and Safety · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05532969 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Henan Provincial People's Hospital
- Last refreshed: 27 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05532969.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing